BruttomessoDCostaSBaritussioA. Continuous subcutaneous insulin infusion (CSII) 30 years later: Still the best option for insulin therapy. Diabetes Metab Res Rev.2009; 25 (2): 99–111.
2.
EQuality1 Study Group–Evaluation of QUALITY of Life and Costs in Diabetes Type 1, NicolucciAMaioneAFranciosiMAmorettiRBusettoECapaniFBruttomessoDDi BartoloPGirelliALeonettiFMorviducciLPonziPVitacolonnaE. Quality of life and treatment satisfaction in adults with Type 1 diabetes: A comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diabet Med.2008; 25 (2): 213–20.
3.
KlupaTBenbenek-KlupaTMaleckiMSzaleckiMSieradzkiJ. Clinical usefulness of a bolus calculator in maintaining normoglycaemia in active professional patients with type 1 diabetes treated with continuous subcutaneous insulin infusion. J Int Med Res.2008; 36 (5): 1112–6.
4.
WalshJRobertsRBaileyT. Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels. J Diabetes Sci Technol.2010; 4 (5): 1174–81.
5.
WalshJRobertsRBaileyT. Guidelines for optimal bolus calculator settings in adults. J Diabetes Sci Technol.2011; 5 (1): 129–35.
6.
KingABArmstrongDU. A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: Bolus dosing. J Diabetes Sci Technol.2007; 1 (1): 42–6.
